Search Results - "Lazarus, Doug"

Abstract 5135: Sustained and controlled in vivo therapeutic levels of drug payloads in tumors using two separate drug combination platforms: Antibody nanoparticle-drug conjugates and multi-drug nanoparticle-drug conjugates, with the potential for improved drug combinability and anticancer effects by Metcalf, Chester A., Poll, Derek van der, Zhao, Liang, Case, Roy I., Lazarus, Doug, Brown, Donna, Halo, Tiffany, Jayaraman, Lata, Peters, Christian, Rohde, Ellen, Eliasof, Scott

“…Abstract Our nanoparticle-drug conjugates (NDCs), created at Cerulean Pharma Inc. by conjugating drug payloads to our novel β-cyclodextrin-PEG (CDP) copolymer,…”
Get full text

Abstract PR10: Significant improvements in therapeutic index for conjugated payloads using a nanoparticle-drug conjugate (NDC) platform to provide sustained drug release and potentially improved anticancer effects by Metcalf, Chester, Poll, Derek van der, Zhao, Liang, Halo, Tiffany, Lazarus, Doug, Stockmann, Adam, Peters, Christian, Brown, Donna, Case, Roy, Rohde, Ellen, Jayaraman, Lata, Wang, Hongwei, Crowell, Tiffany, Senderowicz, Adrian, Eliasof, Scott

“…Abstract Cerulean Pharma Inc.'s Dynamic Tumor Targeting™ Platform creates nanoparticle-drug conjugates (NDCs) designed to significantly mitigate a payload's…”
Get full text